NOD2 and inflammatory bowel disease: Further studies are necessary to conclusively define whether there is a correlation between certain sets of variants, including newly identified variants and previously known variants in Toll-like receptors (TLR)4, 5 and Nucleotide-binding oligomerization domain-containing protein 2 (NOD2) and response to treatment in GSDs with IBD.